Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia
Binet, J.L.; Mentz, F.; Leblond, V.; Merle-Beral, H.
Leukemia 9(12): 2159-2161
1995
ISSN/ISBN: 0887-6924 PMID: 8609738 Document Number: 442893
Document emailed within 1 workday
Related Documents
Canellos, G.P. 1989: The role of alkylating agents in acute and chronic leukemia Bone Marrow Transplantation 4(Suppl 1): 46-47Piro, L.D. 1993: 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma Seminars in Hematology 30(4 Suppl 6: 28-30
O'Brien, S.M. 2014: Targeted agents in chronic lymphocytic leukemia Clinical Advances in Hematology and Oncology: H&o 12 Suppl 3(1): 9-11
Burger, J.A. 2016: Targeted Agents for the Frontline Management of Chronic Lymphocytic Leukemia Clinical Advances in Hematology and Oncology: H&o 14(5 Suppl 8: 7-12
Santini, V.; Gozzini, A.; Scappini, B.; Caporale, R.; Zoccolante, A.; Rigacci, L.; Gelardi, E.; Grossi, A.; Alterini, R.; Ferrini, P.R. 1999: Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells Haematologica 84(10): 897-904
Papadopoulou, M.V.; Bloomer, W.D. 2007: DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents In Vivo 21(2): 175-180
Zeller, W.J.; Berger, M.; Schmähl, D. 1979: Synergistic action of vincristine and adriamycin in the treatment of experimental rat leukemia L5222 Cancer Research 39(3): 1071-1073
Ghaderi, A.A.; Richardson, P.; Cardona, C.; Millsum, M.J.; Ling, N.; Gillis, S.; Ledbetter, J.; Gordon, J. 1988: Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents Leukemia 2(3): 165-170
Ding, W.; Zent, C.S. 2007: Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphoma Clinical Advances in Hematology and Oncology: H&o 5(4): 257-261
Esposito, S.; Taylor, L.A. 1972: The role of deoxyribonuclease in the treatment of chronic lymphocytic leukemia Haematologica 57(12): 803-814
Furman, R.R. 2014: Unmet needs in the treatment of chronic lymphocytic leukemia: introduction Clinical Advances in Hematology and Oncology: H&o 12 Suppl 3(1): 2-5
Ziegler-Heitbrock, H.W.; Munker, R.; Dörken, B.; Gaedicke, G.; Thiel, E. 1986: Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells Cancer Research 46(4 Pt 2): 2172-2178
Klener, P.; Háber, J.; Hausner, P. 1989: Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia Neoplasma 36(2): 215-220
Jain, N. 2019: Optimizing drug dosing for the treatment of chronic lymphocytic leukemia Clinical Advances in Hematology and Oncology: H&o 17(6): 330-331
Wawrzycki, B.; Chodorowska, G.; Pietrzak, A.; Krasowska, D.W.; Wąsik, S.; Dybiec, E.; Lotti, T.; Hercegova, J. 2011: Recurrent skin eruption in patient with chronic lymphocytic leukemia and lymphocytic infiltrates of the dermis resembling Sweet's syndrome Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 146(6): 487-492
Veremko, L.N.; Telegin, L.I.; Pevnitskii, L.A. 1983: Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents Biulleten' Eksperimental'noi Biologii i Meditsiny 95(5): 73-75
Dreger, P.; Schmitz, N. 1997: The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia Leukemia 11(Suppl): S42-S45
Gałeza-Obrepalska, B.; Dwilewicz-Trojaczek, J.; Paszkowska, M.; Kuratowska, Z. 1996: Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia Polski Tygodnik Lekarski 51(19-22): 285-288
Vievskii, A.N. 1994: The synergistic action of quaternary ammonium derivatives and inhibitors of nitrate reduction in respect to Pseudomonas aeruginosa Mikrobiolohichnyi Zhurnal 56(4): 16-20
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285